The Govt-19 epidemic is still killing people worldwide today, while access to vaccines to prevent the disease is highly complex, experts warn.
The World Health Organization (WHO) estimates that more than 223 million people are infected with the SARS-CoV-2 virus.
Of these, more than 4,600,000 died from complications associated with the disease, according to the International Health Organization.
The United States and Europe continue to be the most affected areas, and the countries with the highest number of confirmed cases include the United States, India, Brazil, the United Kingdom and Russia.
In turn, the United States, Brazil, India, Mexico and Peru report the highest number of deaths.
In this complex epidemiological situation, as of this September 6, a total of 5,352 million 927 thousand 296 covid-19 antiviral drugs had been administered.
But the WHO notes that “only 20 percent of people in low- and lower-middle-income countries compare the first dose of the vaccine to 80 percent in upper- and upper-middle-income countries.”
Currently the global panorama of access to vaccines is unacceptable and Kovacs, a multifaceted initiative that guarantees an equitable distribution of these injections, faces various obstacles.
The latter include export restrictions, prioritization of bilateral agreements between manufacturers and countries, current challenges by some major manufacturers to increase production, and delays in applying for regulatory approval.
The WHO insists that the only way to end the epidemic and prevent the emergence of new and rogue strains of the virus is to work together.